Crystal structure of human CD38 extracellular domain

Structure

Volumn 13, Issue 9, 2005, Pages 1331-1339

  Liu, Qun ^a   Kriksunov, Irina A ^a   Graeff, Richard ^b   Munshi, Cyrus ^b   Hon, Cheung Lee ^b   Hao, Quan ^a  

^a Department of Obstetrics Gynecology   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSYL CYCLASE; CD157 ANTIGEN; CD38 ANTIGEN; NICOTINAMIDE ADENINE DINUCLEOTIDE;

AMINO TERMINAL SEQUENCE; APLYSIA; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CRYSTAL STRUCTURE; CRYSTALLOGRAPHY; ENZYME STRUCTURE; ENZYME SUBSTRATE COMPLEX; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDROLYSIS; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DOMAIN;

ADP-RIBOSYL CYCLASE; AMINO ACID SEQUENCE; ANTIGENS, CD38; CATALYSIS; CRYSTALLOGRAPHY; CYCLIC ADP-RIBOSE; EVOLUTION, MOLECULAR; HIV INFECTIONS; HIV-1; HUMANS; HYDROLYSIS; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, TERTIARY; SUBSTRATE SPECIFICITY;

APLYSIA; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 24344490302     PISSN: 09692126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.str.2005.05.012     Document Type: Article

References (52)

1. R. Aarhus, R.M. Graeff, D.M. Dickey, T.F. Walseth, and H.C. Lee ADP-ribosyl cyclase and CD38 catalyze the synthesis of a calcium-mobilizing metabolite from NADP J. Biol. Chem. 270 1995 30327 30333
2. B. Autran, G. Carcelain, T.S. Li, C. Blanc, D. Mathez, R. Tubiana, C. Katlama, P. Debre, and J. Leibowitch Positive effects of combined antriretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease Science 277 1997 112 116
3. A.T. Brunger, P.D. Adams, G.M. Clore, W.L. DeLano, P. Gros, R.W. Grosse-Kunstleve, J.S. Jiang, J. Kuszewski, M. Nilges, and N.S. Pannu Crystallography & NMR system: a new software suite for macromolecular structure determination Acta Crystallogr. D Biol. Crystallogr. 54 1998 905 921
4. S. Bruzzone, L. Guida, L. Franco, E. Zocchi, G. Corte, and A. De Flora Dimeric and tetrameric forms of catalytically active transmemebrane CD38 in transfected HeLa cells FEBS Lett. 433 1998 275 278
5. CCP4 (Collaborative Computational Project, Number 4) The CCP4 suite: programs for protein crystallography Acta Crystallogr. D Biol. Crystallogr. 50 1994 760 763
6. S. Deaglio, U. Dianzani, A.L. Horenstein, J.E. Fernandez, C. van Kooten, M. Bragardo, A. Funaro, G. Garbarino, F. Di Virgilio, J. Banchereau, and F. Malavasi Human CD38 ligand. A 120-KDA protein predominantly expressed on endothelial cells J. Immunol. 156 1996 727 734
7. S. Deaglio, M. Morra, R. Mallone, C.M. Ausiello, E. Prager, G. Garbarino, U. Dianzani, H. Stockinger, and F. Malavasi Human CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member J. Immunol. 160 1998 395 402
8. S. Deaglio, M. Zubiaur, A. Gregorini, F. Bottarel, C.M. Ausiello, U. Dianzani, J. Sancho, and F. Malavasi Human CD38 and CD16 are functionally dependent and physically associated in natural killer cells Blood 99 2002 2490 2498
9. S. Deaglio, A. Capobianco, L. Bergui, J. Durig, F. Morabito, U. Duhrsen, and F. Malavasi CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells Blood 102 2003 2146 2155
10. U. Dianzani, M. Bragardo, D. Buonfiglio, V. Redoglia, A. Funaro, P. Portoles, J. Rojo, F. Malavasi, and A. Pileri Modulation of CD4 lateral interaction with lymphocyte surface molecules induced by HIV-1 gp120 Eur. J. Immunol. 25 1995 1306 1311
11. J. Durig, M. Naschar, U. Schmucker, K. Renzing-Kohler, T. Holter, A. Huttmann, and U. Duhrsen CD38 expression is an important prognostic marker in chronic lymphocytic leukemia Leukemia 16 2002 30 35
12. A. Funaro, A.L. Horenstein, L. Calosso, M. Morra, R.P. Tarocco, L. Franco, A. De Flora, and F. Malavasi Identification and characterization of an active soluble form of human CD38 in normal and pathological fluids Int. Immunol. 8 1996 1643 1650
13. E. Ferrero, and F. Malavasi A natural history of the human CD38 gene H.C. Lee Cyclic ADP-Ribose and NAADP. Structures Metabolism and Functions 2002 Kluwer Academic Publishers Dordrecht, The Netherlands 65 79
14. P. Ghia, G. Guida, C. Scielzo, M. Geuna, and F. Caligaris-Cappio CD38 modifications in chronic lymphocytic leukemia: are they relevant? Leukemia 18 2004 1733 1735
15. R.M. Graeff, T.F. Walseth, H.K. Hill, and H.C. Lee Fluorescent analogs of cyclic ADP-ribose: synthesis, spectral characterization, and use Biochemistry 35 1996 379 386
16. R. Graeff, C. Munshi, R. Aarhus, M. Johns, and H.C. Lee A single residue at the active site of CD38 determines its NAD cyclizing and hydrolyzing activities J. Biol. Chem. 276 2001 12169 12173
17. N. Guex, and M.C. Peitsch SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling Electrophoresis 18 1997 2714 2723
18. A.H. Guse, C.P. da Silva, I. Berg, A.L. Skapenko, K. Weber, P. Heyer, M. Hohenegger, G.A. Ashamu, H. Schulze-Koops, B.V. Potter, and G.W. Mayr Regulation of calcium signalling in T lymphocytes by the second messenger cyclic ADP-ribose Nature 398 1999 70 73
19. M. Hara-Yokoyama, I. Kukimoto, H. Nishina, K. Kontani, Y. Hirabayashi, F. Irie, H. Sugiya, S. Furuyama, and T. Katada Inhibition of NAD+ glycohydrolase and ADP-ribosyl cyclase activities of leukocyte cell surface antigen CD38 by gangliosides J. Biol. Chem. 271 1996 12951 12955
20. M. Hara-Yokoyama, Y. Nagatsuka, O. Katsumata, F. Irie, K. Kontani, S. Hoshino, T. Katada, Y. Ono, J. Fujita-Yoshigaki, and H. Sugiya Complex gangliosides as cell surface inhibitors for the ecto-NAD+ glycohydrolase of CD38 Biochemistry 40 2001 888 895
21. M. Howard, J.C. Grimaldi, J.F. Bazan, F.E. Lund, L. Santos-Argumedo, R.M. Parkhouse, T.F. Walseth, and H.C. Lee Formation and hydrolysis of cyclic ADP-ribose catalyzed by lymphocyte antigen CD38 Science 262 1993 1056 1059
22. T.A. Jones, J.Y. Zou, and S.W. Cowan Improved methods for binding protein models in electron density maps and the location of errors in these models Acta Crystallogr. A 47 1991 110 119
23. P.J. Kraulis MOLSCRIPT: A program to produce both detailed and schematic plots of protein structures J. Appl. Crystallogr. 24 1991 946 950
24. H.C. Lee Enzymatic functions and structures of CD38 and homologs Chem. Immunol. 75 2000 39 59
25. H.C. Lee Physiological functions of cyclic ADP-ribose and NAADP as calcium messengers Annu. Rev. Pharmacol. Toxicol. 41 2001 317 345
26. H.C. Lee Cyclic ADP-ribose and NAADP. A story of two calcium messenger H.C. Lee Cyclic ADP-Ribose and NAADP. Structures, Metabolism and Functions 2002 Kluwer Academic Publishers Dordrecht: The Netherlands 1 21
27. H.C. Lee, and R. Aarhus A derivative of NADP mobilizes calcium stores insensitive to inositol trisphosphate and cyclic ADP-ribose J. Biol. Chem. 270 1995 2152 2157
28. H.C. Lee, T.F. Walseth, G.T. Bratt, R.N. Hayes, and D.L. Clapper Structural determination of a cyclic metabolite of NAD+ with intracellular Ca2+-mobilizing activity J. Biol. Chem. 264 1989 1608 1615
29. H.C. Lee, R. Aarhus, and D. Levitt The crystal structure of cyclic ADP-ribose Nat. Struct. Biol. 1 1994 143 144
30. M.L. Love, D.M. Szebenyi, I.A. Kriksunov, D.J. Thiel, C. Munshi, R. Graeff, H.C. Lee, and Q. Hao ADP-ribosyl cyclase; crystal structures reveal a covalent intermediate Structure 12 2004 477 486
31. F.E. Lund, N. Yu, K.M. Kim, M. Reth, and A.W. Howard Signaling through CD38 augments B cell antigen receptor (BCR) responses and is dependent on BCR expression J. Immunol. 157 1996 1455 1467
32. M.E. Moreno-Garcia, S. Partida-Sanchez, J. Primack, A. Sumoza-Toledo, H. Muller-Steffner, F. Schuber, N. Oppenheimer, F.E. Lund, and L. Santos-Argumedo CD38 is expressed as noncovalently associated homodimers on the surface of murine B lymphocytes Eur. J. Biochem. 271 2004 1025 1034
33. M. Morra, M. Zubiaur, C. Terhorst, J. Sancho, and F. Malavasi CD38 is functionally dependent on the TCR/CD3 complex in human T cells FASEB J. 12 1998 581 592
34. C. Munshi, K.B. Fryxell, H.C. Lee, and W.D. Branton Large scale production of human CD38 in yeast by fermentation Methods Enzymol. 280 1997 318 330
35. C. Munshi, R. Aarhus, R. Graeff, T.F. Walseth, D. Levitt, and H.C. Lee Identification of the enzymatic active site of CD38 by site-directed mutagenesis J. Biol. Chem. 275 2000 21566 21571
36. K. Nata, T. Takamura, T. Karasawa, T. Kumagai, W. Hashioka, A. Tohgo, H. Yonekura, S. Takasawa, S. Nakamura, and H. Okamoto Human gene encoding CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) - organization, nucleotide sequence and alternative splicing Gene 186 1997 285 292
37. J. Navaza AMoRe: an automated package for molecular replacement Acta Crystallogr. A 50 1994 157 163
38. Z. Otwinowski, and W. Minor Processing of X-ray diffraction data collected in oscillation mode Methods Enzymol. 276 1997 307 326
39. S. Partida-Sanchez, D.A. Cockayne, S. Monard, E.L. Jacobson, N. Oppenheimer, B. Garvy, K. Kusser, S. Goodrich, M. Howard, and A. Harmsen Cyclic ADP-ribose production by CD38 regulates intracellular calcium release, extracellular calcium influx and chemotaxis in neutrophils and is required for bacterial clearance in vivo Nat. Med. 7 2001 1209 1216
40. S. Partida-Sanchez, S. Goodrich, K. Kusser, N. Oppenheimer, T.D. Randall, and F.E. Lund Reguation of dendritic cell trafficking by the ADP-ribosyl cyclase CD38: impact on the development of humoral immunity Immunity 20 2004 279 291
41. G.S. Prasad, D.E. McRee, E.A. Stura, D.G. Levitt, H.C. Lee, and C.D. Stout Crystal structure of Aplysia ADP ribosyl cyclase, a homologue of the bifunctional ectozyme CD38 Nat. Struct. Biol. 3 1996 957 964
42. M. Reinis, M. Morra, A. Funaro, R. Di Primio, and F. Malavasi Functional associations of CD38 with CD3 on the T-cell membrane J. Biol. Regul. Homeost. Agents 11 1997 137 142
43. B.V. Roussanov, J.M. Taylor, and J.V. Giorgi Calculation and use of an HIV-1 disease progression score AIDS 14 2000 2715 2722
44. R.L. Stanfield, M.K. Gorny, C. Williams, S. Zolla-Pazner, and I.A. Wilson Structural rationale for the broad neutralization of HIV-1 by human monoclonal antibody 447-52D Structure 12 2004 193 204
45. A.A. Sauve, H.T. Deng, R.H. Angeletti, and V.L. Schramm A covalent intermediate in CD38 is responsible for ADP-ribosylation and cyclization reactions J. Am. Chem. Soc. 122 2000 7855 7859
46. A. Savarino, F. Bottarel, L. Calosso, M.J. Feito, T. Bensi, M. Bragardo, J.M. Rojo, A. Pugliese, I. Abbate, and M.R. Capobianchi Effects of the human CD38 glycoprotein on the early stages of the HIV-1 replication cycle FASEB J. 13 1999 2265 2276
47. A. Savarino, T. Bensi, A. Chiocchetti, F. Bottarel, R. Mesturini, E. Ferrero, L. Calosso, S. Deaglio, E. Ortolan, and S. Butto Human CD38 interferes with HIV-1 fusion through a sequence homologous to the V3 loop of the viral envelope glycoprotein gp120 FASEB J. 17 2003 461 463
48. P.D. Thornton, C. Fernandez, G.M. Giustolisi, R. Morilla, S. Atkinson, R.P. A'Hern, E. Matutes, and D. Catovsky CD38 expression as a prognostic indicator in chronic lymphocytic leukemia Hemato. J. 5 2004 145 151
49. A. Tohgo, H. Munakata, S. Takasawa, K. Nata, T. Akiyama, N. Hayashi, and H. Okamoto Lysine 129 of CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) participates in the binding of ATP to inhibit the cyclic ADP-ribose hydrolase J. Biol. Chem. 272 1997 3879 3882
50. S. Yamamoto-Katayama, M. Ariyoshi, K. Ishihara, T. Hirano, H. Jingami, and K. Morikawa Crystallographic studies on human BST-1/CD157 with ADP-ribosyl cyclase and NAD glycohydrolase activities J. Mol. Biol. 316 2002 711 723
51. A. Vigano, M. Sarasella, S. Rusconi, P. Ferrante, and M. Clerici Expression of CD38 on CD8 T cells predicts maintenance of high viraemia in HAART-treated HIV-1-infected children Lancet 352 1998 1905 1906
52. M. Zubiaur, O. Fernandez, E. Ferrero, J. Salmeron, B. Malissen, F. Malavasi, and J. Sancho CD38 is associated with lipid rafts and upon receptor stimulation leads to Akt/protein kinase B and Erk activation in the absence of the CD3-zeta immune receptor tyrosine-based activation motifs J. Biol. Chem. 277 2002 13 22